Free Trial

Auna (NYSE:AUNA) Hits New 12-Month Low - Here's What Happened

Auna logo with Medical background

Key Points

  • Auna S.A. (NYSE:AUNA) reached a new **52-week low** of $6.09 during trading, closing at $6.21 with a **market capitalization** of $461.84 million.
  • Analysts have recently upgraded Auna, with Wall Street Zen raising it to a **"buy" rating**, while HSBC set a target price of **$7.90.**
  • Auna's latest earnings report revealed an EPS of **$0.19**, exceeding the estimate of $0.16, although revenue fell significantly short of expectations at **$281.43 million.**
  • Interested in Auna? Here are five stocks we like better.

Auna S.A. (NYSE:AUNA - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Friday . The company traded as low as $6.09 and last traded at $6.21, with a volume of 30268 shares traded. The stock had previously closed at $6.14.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AUNA. HSBC set a $7.90 target price on Auna and gave the company a "hold" rating in a report on Thursday, May 22nd. Hsbc Global Res raised Auna to a "hold" rating in a report on Thursday, May 22nd. Finally, Wall Street Zen upgraded shares of Auna from a "hold" rating to a "buy" rating in a research note on Friday, June 6th.

Read Our Latest Stock Report on AUNA

Auna Stock Performance

The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.78 and a current ratio of 0.83. The firm has a market capitalization of $454.42 million, a price-to-earnings ratio of 10.59 and a beta of 2.25. The firm's 50-day moving average price is $6.35 and its two-hundred day moving average price is $7.10.

Auna (NYSE:AUNA - Get Free Report) last announced its quarterly earnings results on Tuesday, May 20th. The company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.03. Auna had a return on equity of 10.39% and a net margin of 3.67%. The firm had revenue of $281.43 million for the quarter, compared to analysts' expectations of $1.12 billion. During the same period in the prior year, the business posted $0.10 earnings per share. Sell-side analysts predict that Auna S.A. will post 0.5 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. Fiera Capital Corp raised its position in Auna by 11.7% in the 1st quarter. Fiera Capital Corp now owns 1,517,685 shares of the company's stock valued at $10,791,000 after purchasing an additional 159,561 shares during the last quarter. Deltec Asset Management LLC lifted its stake in shares of Auna by 2.3% in the 1st quarter. Deltec Asset Management LLC now owns 90,500 shares of the company's stock valued at $643,000 after purchasing an additional 2,000 shares during the period. Goldman Sachs Group Inc. bought a new stake in shares of Auna in the 1st quarter valued at about $219,000. Finally, S Bank Fund Management Ltd bought a new position in shares of Auna during the second quarter worth $126,000.

Auna Company Profile

(Get Free Report)

Auna SA, a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

Featured Articles

Should You Invest $1,000 in Auna Right Now?

Before you consider Auna, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Auna wasn't on the list.

While Auna currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines